The prospective randomized controlled trial of endbronchial ultrasound-guided transbronchial needle aspiration using 22G and 25G aspiration needles for lung cancer
Not Applicable
Recruiting
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000036680
- Lead Sponsor
- ational Cancer Center Hospital East Depertment of Thoracic Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who need multiple lymph node punctures. 2.Patients with hypersensitivity to lidocaine, midazolam, flumazenil, pethidine hydrochloride, or patients with severe hypersensitivity to other drugs. 3.Patients who have clinical symptoms that are interfere in performing bronchoscopy. 4.Patients using antiplatelet drugs or anticoagulants. (It is acceptable if there is an appropriate withdrawal period) 5.Patients judged to be inappropriate by the attending physician. 6.Patients who have participated in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The result of comparing of the the diagnostic accuracy of EBUS-TBNA with a 22-gauge and a 25-gauge aspiration needle in the historogically diagnosis of malignant tumor
- Secondary Outcome Measures
Name Time Method